Joel Lewis - President and CEO, Director at Galectin Therapeutics Inc

Insider Transactions and Holdings

Entity Type
Individual
Role
President and CEO, Director
Stock Symbol
GALT on Nasdaq
All Insider Reports
All Insider Reports

Joel Lewis - trading volume in the past year for Galectin Therapeutics Inc

Holdings reported by Joel Lewis for Galectin Therapeutics Inc

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 897K $3.04M $3.39 Apr 24, 2024 Direct
Restricted Stock Unit 56K $100K $1.79 Jan 24, 2024 Direct Common Stock
Common Stock 2K $6.78K $3.39 Apr 24, 2024 as UTMA custodian for a minor child
Stock Option (right to buy) 91K Jan 24, 2024 Direct Common Stock

Transactions reported by Joel Lewis for Galectin Therapeutics Inc

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.